| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 2e-07 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |